Result of AGM
9 June 2022
(“Instem” or the “Company”)
Result of AGM
Instem (AIM: INS.L), a leading provider of IT solutions to the global life sciences market, announces that at its Annual General Meeting held today, all resolutions were duly passed. The results of the proxy voting position received in advance of the meeting are reported below:
|No.||Resolution||For||% For||Against||% Against||Withheld|
|01||Accounts and Reports||13,886,707||89.98%||1,545,989||10.02%||2,094,614|
|02||Re-elect R A Bandali||17,527,120||100.00%||190||0.00%||0|
|03||Re-elect D M Sherwin||13,727,503||88.95%||1,705,343||11.05%||2,094,464|
|04||Re-elect M F McGoun||13,566,252||87.91%||1,866,594||12.09%||2,094,464|
|08||Allot Equity Securities||16,989,283||96.93%||538,027||3.07%||0|
|09||Make Market Purchases||17,527,310||100.00%||0||0.00%||0|
For further information, please contact:
|Instem plc||Via Walbrook|
|Phil Reason, CEO|
|Nigel Goldsmith, CFO|
|Singer Capital Markets (Nominated Adviser & Joint Broker)||+44 (0) 20 7496 3000|
|Stifel Nicolaus Europe Limited (Joint Broker)||+44 (0) 20 7710 7600|
|Wallbrook Financial PR||Tel: +44 (0) 20 7933 8780|
Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.
Instem solutions are in use by over 700 customers worldwide, including all the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster. Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem products and services address aspects of the entire drug development value chain, from discovery through to market launch. Management estimate that over 50% of all drugs on the market have been through some part of Instem's platform at some stage of their development.
To learn more about Instem solutions and its mission, please visit instem.com.